Novartis buys S Africa-based Aspen’s Japanese generic unit for up to $440m

Novartis buys S Africa-based Aspen’s Japanese generic unit for up to $440m

Photo: Reuters

11 November, 2019

aspen pharma Novartis Sandoz

Printed by Unregistered user on Thu, 25 Dec 2025 02:21:41 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Novartis to acquire Japanese giant Takeda's eye drug assets for $3.4b

Novartis sells Sandoz US dermatology, generics portfolio to Aurobindo for $900m

Read more from World

Viewpoint: The structural case for APAC private credit in 2026

Blackstone to acquire Australia’s iconic Hamilton Island for $1b